Holen Sie sich die Stockscreener-App
14.24
0.49%
-0.07
Handel nachbörslich:
14.22
-0.02
-0.14%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KVUE?
Forum
Prognose
Dividendenhistorie
Kenvue Inc Aktie (KVUE) Neueste Nachrichten
Will Kenvue Inc. stock hit analyst forecastsMarket Movers & Verified Technical Signals - newser.com
Kenvue stock hits 52-week low at 14.04 USD By Investing.com - Investing.com Canada
Earnings Preview: Kenvue (KVUE) Q3 Earnings Expected to Decline - Yahoo! Finance Singapore
Jefferies Lowers Kenvue (KVUE) PT to $23, Cites Macroeconomic Headwinds for Consumer Health - Yahoo Finance
The Escalator: Organon, Kenvue, Real Chemistry and more - Medical Marketing and Media
What valuation ratios show for Kenvue Inc. (J4D) stockJuly 2025 Recap & Advanced Technical Signal Analysis - newser.com
Whalen Wealth Management Inc. Acquires New Position in Kenvue Inc. $KVUE - MarketBeat
Tick level data insight on Kenvue Inc. volatilityWeekly Loss Report & Weekly High Return Forecasts - newser.com
How strong is Kenvue Inc. stock earnings growth2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com
Does Kenvue (KVUE) Balance Legal Risks and Payouts With a Prudent Capital Allocation Strategy? - simplywall.st
Understanding Kenvue Inc.’s price movementJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
Wealthfront Advisers LLC Has $3.41 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue (KVUE) Expected to Announce Earnings on Thursday - MarketBeat
Will Kenvue Inc. stock sustain bullish trend into 2025Gap Up & High Yield Stock Recommendations - newser.com
Can trapped investors hope for a rebound in Kenvue Inc.Global Markets & Free Reliable Trade Execution Plans - newser.com
How Kenvue Inc. stock performs in weak economyForecast Cut & Technical Pattern Recognition Alerts - newser.com
Kenvue: Remains A Sell Until The Dividend Is Cut (NYSE:KVUE) - Seeking Alpha
Leading vs lagging indicators on Kenvue Inc. performanceJuly 2025 Patterns & Consistent Profit Alerts - newser.com
Real time scanner hits for Kenvue Inc. explainedEarnings Recap Summary & Consistent Income Trade Recommendations - newser.com
How geopolitical risks impact Kenvue Inc. stock2025 Institutional Moves & Fast Moving Market Watchlists - newser.com
PRODUCTS LIABILITY (DRUGS)—Tex. Dist.: Texas cites twenty-six epidemiological studies in Tylenol marketing suit against Johnson & Johnson, Kenvue - VitalLaw.com
Paxton sues Johnson & Johnson, Kenvue over Tylenol marketing to pregnant women - crossroadstoday.com
US health chief says there is not enough data to show Tylenol causes autism - Reuters
RFK Jr. says Tylenol in pregnancy, autism link is 'very suggestive' - Seeking Alpha
Texas Attorney General Sues Tylenol Makers Over Alleged Autism Risk - Law Commentary
Kenvue: Temporary Headwinds Don't Derail Its Consumer Health Dominance And 5.5% Dividend Yield - Seeking Alpha
Kenvue to tap Jon Halvorson as new chief marketing officer - Medical Marketing and Media
Texas AG sues J&J, Kenvue over Tylenol pregnancy warnings - NJBIZ
Mixed options sentiment in Kenvue Inc with shares down 2.72% - TipRanks
Deutsche Bank Lowers Kenvue (KVUE) PT to $18, Keeps a Hold Rating - Insider Monkey
December 2026 Options Now Available For Kenvue (KVUE) - Nasdaq
Texas Tylenol Lawsuit Accuses J&J of Failing To Warn of Autism Risks - AboutLawsuits.com
Kenvue Hires P&G Exec to Aid Rebound From Tylenol Fallout - Bloomberg.com
The Scoop: Amazon’s layoff memo cuts through public speculation - PR Daily
Texas Sues Tylenol Over Alleged Autism Link - Northwest Signal
Kenvue Keeps Quarterly Dividend at $0.2075 a Share, Payable Nov. 26 to Holders of Record Nov. 12 - MarketScreener
Trump Trade: Texas sues Kenvue, J&J over Tylenol autism risk - TipRanks
Canaccord downgrades Tylenol maker Kenvue as legal risks cloud turnaround - Investing.com
Kenvue Inc. Declares Quarterly Cash Dividend, Payable on November 26, 2025 - MarketScreener
Will Kenvue Inc. stock outperform tech sector in 2025Buy Signal & Breakout Confirmation Trade Signals - newser.com
Mizuho Markets Americas LLC Decreases Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Canaccord Genuity Downgrades Kenvue to Hold From Buy, Adjusts Price Target to $15 From $26 - MarketScreener
Kenvue downgraded to Hold at Canaccord amid negative headlines - TipRanks
Kenvue Declares Quarterly Cash Dividend - Bluefield Daily Telegraph
Kenvue (KVUE): Assessing Valuation as Legal Risks and Leadership Shifts Raise New Questions - Yahoo Finance
Texas Sues Kenvue, Alleging Deceptive Tylenol Marketing - The Business of Fashion
Teacher Retirement System of Texas Has $18.91 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
D.A. Davidson & CO. Sells 74,699 Shares of Kenvue Inc. $KVUE - MarketBeat
Texas sues Tylenol makers J&J and Kenvue, claiming they hid drug's autism risks | Health | swoknews.com - The Lawton Constitution
Paxton sues Tylenol company over autism claims - Marshall News Messenger
Texas sues Johnson & Johnson over Tylenol autism warningsCHOSUNBIZ - Chosun Biz
Johnson & Johnson, Kenvue slammed with state lawsuit over Tylenol autism claims - Insurance Business America
Texas sues Johnson & Johnson over Tylenol-autism link claims - KEYE
Texas Waves ‘MAHA’ Flag With Complaint Alleging Autism Link To Prenatal Acetaminophen Exposure - Citeline News & Insights
Texas Sues Tylenol Makers, Claiming They Hid Autism Risks - The New York Times
Texas sues Kenvue claiming it hid link between Tylenol and autism - drugdiscoverytrends.com
Texas sues Tylenol makers J&J and Kenvue, claiming they hid drug's autism risks - Reuters
Kenvue hiring Mondelēz exec as new chief marketing officer amid Tylenol woes - Seeking Alpha
Texas sues Tylenol makers over disproven claims about autism - MSNBC News
Texas sues Tylenol makers over alleged links to autism, ADHD - Jurist.org
Mixed options sentiment in Kenvue Inc with shares down 3.55% - TipRanks
Exclusive | Embattled Tylenol Maker Kenvue Hires New Marketing Chief - The Wall Street Journal
Hold Rating for Kenvue, Inc.: Legal Challenges and Sales Decline Amidst Growth Potential - TipRanks
Texas AG Paxton sues Tylenol makers over alleged link to autism - NewsNation
Texas Suit Accuses Tylenol Maker of Hiding a Link to Autism - The Wall Street Journal
0.26%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):